TOP > UK-Japan GT WORKSHOP




Sponsorship: British Embassy
Support: JSGT, BSGT, ISCGT, JMU 21st Century COE Program
Date: Thursday 12th October 2006
Venue: British Embassy New Hall

08:30 | Registration

09:00 | Welcome Greetings --- Edward Wright
09:05 | Opening Remarks --- Keiya Ozawa
09:10 | Introduction of UK Speakers --- Matthew J.A. Wood
09:15 | Introduction of Japanese Speakers --- Keiya Ozawa

Chairperson: Takashi Shimada
09:20 | 09:40 Adrian Thrasher, Institute of Child Health, London
@@@gGene therapy strategies for immunodeficiencyh
09:40 | 10:00 Masafumi Onodera, University of Tsukuba
@@@gCurrent situation of stem cell gene therapy in Japanh
10:00 | 10:20 M. Yvonne Alexander, University of Manchester
@@@gMolecular and cellular strategies to prevent atherosclerotic plaque developmenth

Chairperson: Matthew J.A. Wood
10:35 | 10:55 Keiya Ozawa, Jichi Medical University
@@@gApplications of AAV to gene therapyh
10:55 | 11:15 Andrew H. Baker, University of Glasgow
@@@gViral vector design for targeted in vivo gene deliveryh
11:15 | 11:35 Takashi Shimada, Nippon Medical School
@@@gGene therapy of lysosomal storage disorders with neurological lesionsh
11:35 | 11:55 Leonard W. Seymour, University of Oxford
@@@gSystemic delivery of oncolytic adenovirusesh

Chairperson: Keiya Ozawa
13:00 | 13:20 Kohnosuke Mitani, Research Center for Genomic Medicine, Saitama Medical School
@@@gGene targeting with viral vectors for gene therapy and stem cell researchh
13:20 | 13:40 James Birchall, Cardiff University
@@@gMicroneedles for cutaneous cell and gene therapyh
13:40 | 14:00 Makoto Inoue, DNAVEC Corporation
@@@gTechnology and application on a new class cytoplasmic RNA vector, Sendai virus vectorh
14:00 | 14:20 Norman J. Maitland, University of York
@@@gCancer stem cells: are they the basis of tumour recurrence after treatment for prostate cancer?h

Chairperson: Leonard W. Seymour
14:30 | 14:50 Yasufumi Kaneda, Osaka University
@@@gDevelopment of cancer treatment strategies based on HVJ envelope vector systemh
14:50 | 15:10 Andrew D. Miller, Imperial College London
@@@gSynthetic, self assembly ABCD nanoparticles; nanomedicine solutions for gene therapy applications?
15:10 | 15:30 Makiya Nishikawa, Kyoto University
@@@gEfficient delivery of therapeutic genes and short hairpin RNA by intravascular injection of naked plasmid DNAh
15:30 | 15:50 Matthew J.A. Wood, University of Oxford
@@@gNucleic acid therapies for neuromuscular diseaseh

16:00 | Registration for Open Session
16:30 | 18:00 Open Session gTowards UK-Japan Gene Therapy Collaborationh
16:30 | 16:35 Opening Remarks --- Edward Wright

Chairpersons: Matthew J.A. Wood & Keiya Ozawa
16:35 | 16:55 Keynote Speech on Gene Therapy in the UK
@@@(I) 16:35 | 16:45 Leonard W. Seymour, University of Oxford
@@@(II) 16:45 | 16:55 Adrian Thrasher, Institute of Child Health, London
16:55 | 17:15 Keynote Speech on Gene Therapy in Japan
16:55 | 17:05 Takashi Shimada, Nippon Medical School
@@@gFocusing on viral vector mediated gene therapyh
17:05 | 17:15 Yasufumi Kaneda, Osaka University
@@@gDevelopment of non-viral vectors in Japanh
17:15 | 17:30 Summary of Closed Session
@@@UK side --- Matthew J.A. Wood, University of Oxford
@@@Japan side --- Keiya Ozawa, Jichi Medical University
17:30 | 17:50 Q & A and General Discussion
17:50 | 17:55 Conclusions --- Keiya Ozawa
17:55 | 18:00 Closing Remarks --- Edward Wright
18:00 | 19:30 Reception

The 2nd UK-Japan GT Workshop 2006vO(PDF 252KB)


UK-Japan Gene Therapy Workshop / ISCGT
(International Society for Cell and Gene Therapy of Cancer)
Joint Session
"Cancer Gene Therapy from Bench to Clinic"

Programme

Date: Saturday 14th October 2006
Time: 08:30-12:00
Venue: Makuhari-Messe International Conference Hall

Chairs: Len Seymour, University of Oxford
Keiya Ozawa, Jichi Medical University

Presentation time for speakers: 18min
15 min presentation with 3 min discussion

JS-1 Len Seymour, University of Oxford
@@@Systemic delivery of oncolytic adenoviruses

JS-2 Tomoki Todo, University of Tokyo
@@@Oncolytic virus therapy using genetically engineered herpes simplex Viruses

JS-3 Andrew Baker, University of Glasgow
@@@Viral vector design for targeted in vivo gene delivery

JS-4 Hirofumi Hamada, Sapporo Medical University
@@@Antibody-targeted selective gene delivery through FZ33 fiber-modified adenoviral vectors

JS-5 James Birchall, Cardiff University
@@@Microneedles for cutaneous cell and gene therapy

JS-6 Kazuyuki Matsushita, Chiba University
@@@Transcriptional c-myc suppressor FUSE-binding protein (FBP)-interacting repressor for cancer gene therapy

JS-7 Norman Maitland, York University
@@@Cancer Stem Cells: are they the basis of tumour recurrence after treatment for prostate cancer?

JS-8 Takashi Okada, Jichi Medical University
@@@Vector-producing tumor-tracking stem cells for suicide cancer gene therapy

JS-9 Andrew Miller, Imperial College London
@@@Synthetic, self assembly ABCD nanoparticles; nanomedicine solutions for gene therapy applications?

JS-10 Jun Yoshida, Nagoya University
@@@Design/development and manufacture of processed cells and non-viral vector for clinical research